share

25-Hydroxydihydrotachysterol(3) CAS NO 25631-39-4


Unit Price:

CAS No.:25631-39-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

25-Hydroxydihydrotachysterol(3) CAS NO 25631-39-4 is a synthetic analog of vitamin D, specifically a hydroxylated derivative of dihydrotachysterol. This compound is of significant value in pharmaceutical research and development due to its role in studying calcium and phosphate metabolism, as well as its potential applications in treating bone disorders. It is primarily needed by research institutions, pharmaceutical manufacturers, and fine chemical suppliers focused on developing treatments for conditions like hypoparathyroidism, renal osteodystrophy, and vitamin D-resistant rickets.

Application

  • Pharmaceutical Intermediate: Serves as a key synthetic precursor in the production of advanced vitamin D analogs and active pharmaceutical ingredients (APIs).
  • Biochemical Research: Used as a reference standard and experimental compound in studies of vitamin D receptor (VDR) activation and calcium homeostasis.
  • Metabolic Disorder Studies: Applied in preclinical research for investigating and modeling bone metabolism diseases.
  • Analytical Standard: Employed as a high-purity certified reference material (CRM) for quality control and method validation in analytical laboratories.
  • Nutraceutical Development: Explored for potential use in advanced dietary supplements targeting bone health, subject to regulatory approval.

Basic Information

Product Name 25-Hydroxydihydrotachysterol(3)
CAS No. 25631-39-4
Molecular Formula C28H46O2
Molecular Weight 414.67 g/mol
Synonyms 25-Hydroxy DHT3; 25-Hydroxydihydrotachysterol 3; (5E,7E)-9,10-Secocholesta-5,7,10(19)-trien-3β,25-diol; Dihydrotachysterol 25-ol; AT-10 derivative; 25-OH-DHT; Vitamin D analog 25631-39-4
EINECS Contact for details

Quality Control

Our 25-Hydroxydihydrotachysterol(3) is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store under an inert atmosphere (e.g., nitrogen or argon) at controlled room temperature (15-25°C) to minimize oxidation and degradation. The container should be kept in a cool, dry, and well-ventilated place, away from heat and incompatible materials.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to reference spectrum
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0%
Any single unknown impurity ≤ 0.5%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.